Ampicillin in the treatment of brucellosis: A controlled therapeutic trial
AUTOR(ES)
McDevitt, D. G.
RESUMO
McDevitt, D. G. (1970).Brit. J. industr. Med.,27, 67-71. Ampicillin in the treatment of brucellosis: A controlled therapeutic trial. A controlled therapeutic trial has been carried out with ampicillian in the treatment of brucellosis. Sixty-eight people, veterinary surgeons or their unqualified assistants, with serological evidence of brucella antibodies measured by the anti-human globulin (Coombs) test and the complement-fixation test, some of whom had symptoms consistent with a diagnosis of brucellosis, were treated in two random groups. One group was given ampicillin, 1 g. four times a day for 28 days; the other took a placebo in identical capsules for the same period. The response to treatment was gauged by subjective improvement in symptoms four weeks after its completion and by serological improvement after four months. Fifty-four people completed the trial.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1009044Documentos Relacionados
- Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.
- Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
- Enzyme Immunoassays for Serological Diagnosis of Bovine Brucellosis: A Trial in Latin America
- Brucellosis: the situation in Britain.
- An unusual presentation of brucellosis: acute hepatitis
